Use of atropinic drugs remains controversial in Parkinson's disease (PD) because there is insufficient evidence about their efficacy and they can induce serious adverse drug reactions. Atropinic risk scales were developed to help to identify atropinic drugs in prescription forms and to evaluate their burden in clinical practice. In the present review, we discuss the few studies investigating atropinic burden in PD and present the results of our study indicating that atropinic drugs are still widely prescribed in PD (almost 3 of 5 prescriptions) with a clinically significant atropinic burden in around 1 of 6 PD patients. Drugs mainly responsible for high values of atropinic burden were those used for nonmotor symptoms. Clinically significant atropinic burdens were mainly induced by associations of several "low-risk" drugs. Physicians must be aware that in addition to classical atropinic antiparkinsonian drugs, many others (psychotropics) can contribute to increased atropinic burden in PD patients. © 2016 International Parkinson and Movement Disorder Society.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mds.26595 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A High Postoperative Atropinic Burden is Associated with Postoperative Delirium in Elderly Patients with Hip Fracture: Results of the Prospective, Observational, ATROPAGE Trial.
Clin Interv Aging
January 2023
Département d'Anesthésie-Réanimation et de Médecine Péri Opératoire, Centre Hospitalo-universitaire (CHU) de Toulouse, Toulouse, France.
Background: Postoperative frequently occurs in the elderly after hip fracture surgery and is associated with poor outcomes. Our aim was to identify a correlation between the atropinic burden (AB) due to drugs with clinical antimuscarinic effect and the occurrence of postoperative .
Methods: We carried out a prospective, monocentric, observational study including 67 patients over 65 years of age who underwent hip fracture surgery.
Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
Eur J Clin Pharmacol
December 2019
UMR INSERM 1027, Université de Toulouse, Centre Hospitalo-Universitaire de Toulouse (CHU Toulouse), Toulouse, France.
Purpose: With increasing age, adults are often exposed to anticholinergic drugs and are prone to potential adverse drug reaction, among which cognitive impairment. If the short-term cognitive effects of anticholinergic drugs are well established, their long-term cognitive effects have less been studied.
Objective: To provide a systematic review of longitudinal studies which assessed the effect of anticholinergic exposure on cognition in individuals over 50 years.
[Evolution of drug prescription pattern in elderly: Retrolective study in a general hospital center in France].
Therapie
March 2021
Inserm UMR 1027, service de pharmacologie médicale et clinique, centre de pharmacovigilance, de pharmacoepidémiologie et d'informations sur le médicament Occitanie Ouest, faculté de médecine, centre hospitalier universitaire et faculté de médecine de l'université de Toulouse, 31000 Toulouse, France.
Background: Collaboration between general practitioners and hospital clinicians remains a major challenge for the healthcare system.
Objective: The aim of this study was to evaluate the pattern of drug prescription after an hospital stay in geriatric rehabilitation department of Bagnères-de-Bigorre hospital center, over a one year period.
Method: Quantitative and qualitative analysis of drug prescriptions for patients during their hospital admission and followed up at 6 and 12 months after their discharge.
Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database.
Fundam Clin Pharmacol
August 2019
Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire et Faculté de Médecine, 37 allées Jules Guesde, 31000, Toulouse, France.
Atropinic drugs are known to potentially induce physical and/or mental impairments in the elderly. The aim of this study was to investigate trends of atropinic exposure in patients ≥65 years in France between 2006 and 2015. A repeated cross-sectional study was performed quarterly from January 1, 2006 to December 31, 2015, in the 'Echantillon Généraliste des Bénéficiaires (EGB)', a representative sample of the French population.
View Article and Find Full Text PDFHigher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties.
Fundam Clin Pharmacol
June 2019
Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Childhood digestive disorders are a common occurrence and are sometimes unexplained. Maternal medication during the development of the foetus' digestive system may contribute to the increase in childhood digestive disorders, especially with drugs acting on the cholinergic system. This study investigated the association between prenatal exposure to drugs with atropinic properties and the use of digestive disorder medications in childhood (0-3 years).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!